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mHR23B encodes one of the two mammalian homologs of Saccharomyces cerevisiae RAD23, a ubiquitin-like
fusion protein involved in nucleotide excision repair (NER). Part of mHR23B is complexed with the XPC
protein, and this heterodimer functions as the main damage detector and initiator of global genome NER.
While XPC defects exist in humans and mice, mutations for mHR23A and mHR23B are not known. Here, we
present a mouse model for mHR23B. Unlike XPC-deficient cells, mHR23B/ mouse embryonic fibroblasts are
not UV sensitive and retain the repair characteristics of wild-type cells. In agreement with the results of in vitro
repair studies, this indicates that mHR23A can functionally replace mHR23B in NER. Unexpectedly,
mHR23B/ mice show impaired embryonic development and a high rate (90%) of intrauterine or neonatal
death. Surviving animals display a variety of abnormalities, including retarded growth, facial dysmorphology,
and male sterility. Such abnormalities are not observed in XPC and other NER-deficient mouse mutants and
point to a separate function of mHR23B in development. This function may involve regulation of protein
stability via the ubiquitin/proteasome pathway and is not or only in part compensated for by mHR23A.
Nucleotide excision repair (NER) is the major repair system
for the removal of DNA lesions induced by UV light and
numerous chemical agents (12, 49). The cut-and-patch-type
reaction mechanism involves the concerted action of more
than 25 proteins, sequentially implicated in recognition of
DNA damage, unwinding of the DNA around the lesion, ex-
cision of a single-stranded piece of DNA containing the dam-
age, and subsequent gap filling DNA synthesis and ligation
(10). NER consists of two subpathways. Genome-wide repair is
taken care of by the global genome NER (GG-NER) process,
acting irrespective of the genomic location of the lesion or cell
cycle stage. However, some lesions (e.g., UV-induced cyclobu-
tane pyrimidine dimers) are repaired less efficiently by GG-
NER. To prevent such lesions from obstructing the vital pro-
cess of transcription for too long, the transcription-coupled
NER (TC-NER) subpathway acts as a fast backup system for
clearing the template strands of actively transcribed genes (16,
17).
Defective NER is associated with three clinically and genet-
ically heterogeneous human syndromes: xeroderma pigmento-
sum (XP), Cockayne syndrome (CS), and trichothiodystrophy
(TTD) (3). Patients suffering from XP (complementation
groups XP-A to XP-G) exhibit severe sensitivity to sunlight
(UV), ocular symptoms, and cutaneous abnormalities, includ-
ing a very strong predisposition to develop skin cancer. Most
XP patients carry defects in GG-NER and TC-NER, but only
the GG-NER pathway is affected in XP-C patients (43–45).
The XPC protein is essential for GG-NER of various types
of DNA damage and is found in a tight complex with hHR23B,
one of the two human homologs of the Saccharomyces cerevi-
siae DNA repair protein RAD23 (26). hHR23B stimulates the
repair activity of XPC in in vitro reconstitution assays with
recombinant proteins (37). A 56-amino-acid segment with a
predicted helical amphipathic structure containing the XPC-
binding domain of hHR23B appears sufficient for XPC stim-
ulation. This suggests that hHR23B has a structural rather
than catalytic function (25). A vast majority of XPC protein is
bound to hHR23B in vivo. However, in vitro, hHR23A, the
second human homolog of RAD23, can substitute for hHR23B
in binding and stimulating XPC. This opens the possibility that
both proteins are functionally interchangeable to some extent
(39, 41). The XPC-hHR23B complex has been identified as the
primary DNA damage sensor that initiates GG-NER and has
been shown to interact directly with the essential repair and
transcription factor TFIIH in vivo and in vitro (38, 50). The
XPC-hHR23B complex senses different types of damage based
on disrupted base pairing and stimulates the association of
TFIIH with damaged DNA in cell extracts (50). After the
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initial subpathway-specific lesion detection, the XPB and XPD
helicase subunits of TFIIH open the DNA helix around the
lesion. XPA together with the heterotrimeric replication pro-
tein A may function as a common damage verifier before the
DNA is incised on both sides of the injury by the XPG and
ERCC1/XPF endonucleases (10, 50).
In addition to the XPC-binding domain, S. cerevisiae and
mammalian RAD23 proteins harbor an amino-terminal ubiq-
uitin-like (UbL) moiety and two so-called ubiquitin-associated
(UBA) domains (21, 25). In S. cerevisiae, the UbL domain is
indispensable for the repair function of RAD23 (28, 48).
Moreover, hHR23A and hHR23B interact with the S5a sub-
unit of the 26S proteasome, and hHR23A serves as a substrate
for E6-associated protein-mediated ubiquitination (20, 23).
These findings strongly suggest that the RAD23 homologs are
involved in the ubiquitin/proteasome pathway.
Although hHR23A can functionally replace hHR23B in
vitro during NER, it is unknown whether and to which extent
these two human RAD23 homologs can substitute for each
other in vivo. Moreover, while for most other NER genes,
natural and/or laboratory-made human and rodent mutant cell
lines are available, HR23-deficient cell lines have not been
described. Thus, to address the biological relevance of mam-
malian RAD23 homologs and their relationship to XPC in
NER, we have inactivated the mouse homolog of HR23B
(mHR23B) by gene targeting. In the present paper, we describe
the phenotypes of mHR23B-deficient mice and cells.
MATERIALS AND METHODS
Construction of mHR23B targeting vector. Isogenic mouse genomic DNA was
isolated from an Ola129-derived phage lambda library after probing with human
HR23B cDNA sequences. A 13.6-kb SalI fragment, containing three exons (ex-
ons II to IV), was subcloned into the SalI site of a pUC vector, designated
pMHR23B1 (16.5 kbp). Following several subcloning steps, a 2.5-kb EcoRI
fragment (containing exon II) was cloned at the ClaI site and a 4.5-kb NcoI-SacI
fragment (containing exon IV) was positioned between the NotI-SacII sites of
the targeting vector pMHR23B-UMS-E3 (6.9 kb) representing the 5 and 3
arms of homology, respectively. Thus, in the targeting vector, exon III (amino
acids 148 to 228) was replaced with a cassette containing (PGK promoter-driven)
neomycin resistance gene and an upstream mouse sequence (described as a
transcriptional stop sequence [19]). The vector also contained the negative se-
lectable marker HSV-TK (herpes simplex virus thymidine kinase gene).
ES cell culture and transfection. The Ola129-derived embryonic stem (ES)
cell line E14 was electroporated with the mHR23B targeting construct and
cultured on dishes treated with gelatin as described previously (40). G418 (Ge-
neticin; Gibco) was added 24 h after electroporation to a final concentration of
200 g/ml, and the cells were maintained under selection for 6 to 8 days.
Genomic DNA from individual G418-resistant clones was digested with SacI and
analyzed by Southern blotting using a genomic PCR fragment (255 bp), isolated
between SacI-EcoRI sites (upstream of exon II), as a probe. Targeted clones,
with the correct hybridizing SacI fragments, were subsequently screened with a
fragment of the neomycin resistance gene as a probe to confirm proper homol-
ogous recombination.
Generation of the mHR23B-deficient mice and fibroblasts. Cells of mHR23B-
targeted clones were karyotyped, and ES cells from two independent clones with
40 chromosomes were injected into 3.5-day-old blastocysts isolated from preg-
nant C57BL/6 female mice (40). Male chimeric mice were mated with C57BL/6
females to obtain heterozygote animals. Germ line transmission was observed in
the coat color of the F1 offspring. Heterozygous male and female mice were
interbred to generate mHR23B/, mHR23B/, and mHR23B/ mice. Geno-
typing was performed by Southern blotting with genomic DNA prepared from
tail biopsies of 10- to 14-day-old pups.
Primary mouse embryonic fibroblasts (MEFs) (at least three independent lines
per genotype) were isolated from day 13.5 embryos obtained from matings
between mHR23B/ mice (F1). Part of the embryo was used for genotyping.
The remaining embryonic tissue was minced using a pair of scissors and im-
mersed in a thin layer of culture medium (Dulbecco modified Eagle medium with
10% fetal calf serum [Gibco BRL]) supplemented with 15% fetal calf serum,
2 mM glutamate, 50 g of penicillin per ml, and 50 g of streptomycin per ml.
Northern blot analysis. Total RNA samples (20 g) were separated on 0.9%
agarose gel and transferred to Hybond-N membrane (Amersham Pharma-
cia Biotech). Total RNA was isolated from mHR23B MEFs using the acid
guanidinium-phenol-chloroform (AGPC) method described previously (5).
RNA blots were hybridized using 32P-labeled mHR23A and mHR23B cDNA
probes.
Protein analysis. Immunoblot analysis of mHR23B protein was performed on
fibroblast extracts obtained by sonification (5  106 cells in 300 l of phosphate-
buffered saline containing phenylmethylsulfonyl fluoride and CLAP [chymosta-
tin, leupeptin, antipain, and pepstatin A]). Eighty micrograms of total cellular
protein per lane was separated on sodium dodecyl sulfate–8% polyacrylamide
gels, blotted to nitrocellulose filters (Schleicher & Schuell), and probed with
rabbit polyclonal antibodies recognizing mHR23B. Bands were visualized using
peroxidase-conjugated secondary antibodies.
DNA repair assays. UV sensitivity was determined as described previously
(36). MEF cultures were exposed to different doses of UV-C (254-nm-wave-
length light; Philips TUV lamp) and allowed to grow for another 3 to 5 days
before reaching confluence. The number of proliferating cells was estimated by
scintillation counting of the radioactivity incorporated during a 3-h pulse with
[3H]thymidine (5 Ci/ml; specific activity [SA], 40 to 60 Ci/mmol; Amersham).
Cell survival was expressed as the ratio of 3H incorporated in irradiated cells to
3H incorporated in nonirradiated cells.
UV-induced global genome repair was assayed using the unscheduled DNA
synthesis (UDS) method described previously (47). In short, cells grown on
coverslips were exposed to 254-nm-wavelength UV light (16 J/m2) and labeled
with [methyl-3H]thymidine (10 Ci/ml; SA, 40 to 60 Ci/mmol). Repair capacity
was quantified by counting grains after autoradiography.
RNA synthesis recovery after UV irradiation (27) was measured as follows.
Cells were labeled with [2-14C]thymidine (0.05 Ci/ml; SA, 56 Ci/mmol) for 24 h,
exposed to different doses of 254-nm-wavelength UV light, allowed to recover for
16 h, labeled with [5,6-3H]uridine (10 Ci/ml; SA, 47 Ci/mmol) for 1 h, and
processed for scintillation counting. The relative rate of RNA synthesis was
expressed as the ratio of radioactivity in UV-irradiated cells to that in nonirra-
diated cells. Comparable results were also obtained by counting grains after
autoradiography. The relative rate of RNA synthesis was expressed as the num-
ber of autoradiographic grains over the UV-exposed nuclei divided by the num-
ber of grains over the nuclei of nonirradiated cells on parallel slides (data not
shown).
Histology and electron microscopical analysis. For histological examination,
dissected tissues fixed in Bouin or in 10% neutral buffered formalin were pro-
cessed and embedded in paraffin. Mounted sections (5 to 8 m thick) were
stained with hematoxylin and eosin using routine procedures.
For transmission electron microscopy, small pieces of tissue were fixed in
buffered 4% paraformaldehyde and postfixed in 1% OsO4 plus K3Fe(CN)6 (9).
After the tissue samples were dehydrated and embedded in Epon, 1-m-thick
sections were cut and stained with methylene blue.
RESULTS
Targeted disruption of the mouse mHR23B gene. The mouse
mHR23B locus was isolated and partly characterized. Deletion
of exon III not only removes the sequence encoding amino acid
residues 148 to 228 of the mHR23B protein but also results in
a frameshift and accordingly is expected to give rise to a null
allele (Fig. 1A). Following transfection of ES cell line E14,
properly targeted heterozygous ES cells were obtained at a
frequency of 21% (Fig. 1B). Two independent ES clones for
which the absence of visible chromosomal abnormalities and
additional randomly integrated constructs had been verified
(data not shown) were used for blastocyst injections. Germ line
transmission was obtained for both clones. Heterozygous off-
spring from matings between chimeric males and C57BL/6
female mice were intercrossed in order to generate homozy-
gous mutant mHR23B animals (Fig. 1C). In parallel, these
matings served to isolate MEFs of different genotypes from
day 13.5 embryos. The effect of targeted disruption on the
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expression of the mHR23B gene was analyzed in MEFs:
neither mHR23B mRNA nor mHR23B protein could be de-
tected in mHR23B/ cells by RNA and immunoblot analyses,
respectively (Fig. 1D and E). We conclude that we have cre-
ated mHR23B null mutants. Homozygous mouse mutants and
cell lines from the two independent ES transformants yielded
identical results in all subsequent studies, indicating that the
findings reported below are not due to uncontrolled events that
might have occurred in one targeted ES clone but are the
result of mHR23B inactivation.
FIG. 1. Targeted disruption of the mHR23B gene by homologous recombination. (A) Genomic organization and disruption strategy for
mHR23B showing the gene, the targeting construct, and the targeted mHR23B allele. Exon III is deleted, and the upstream mouse sequence and
Neo cassettes are inserted between exon II and exon IV. (B) Southern blot analysis of SacI-digested DNA from ES cells showing the 9.6-kb and
5.5-kb fragments representing the wild-type and targeted alleles of mHR23B, respectively. (C) Southern blot analysis of SacI-digested tail DNA
from mHR23B/, mHR23B/, and mHR23B/ mice. (D) RNA blot analysis of mHR23B mRNA in cellular extracts from mHR23B/,
mHR23B/, and mHR23B/ MEFs using mHR23B cDNA as a probe. As a loading control for the amount of RNA, the blot was reprobed with
mHR23A cDNA (data not shown). (E) Immunoblot analysis of mHR23B protein in cellular extracts from mHR23B/, mHR23B/, and
mHR23B/ MEFs using polyclonal antibodies against the human HR23B protein (top blot). Polyclonal antibodies against the human HR23A
protein (bottom blot) and the human XPC protein (data not shown) were used as a loading control and to check whether mHR23A protein is
expressed in mHR23B MEFs. The asterisks indicate aspecific cross-reacting bands.
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mHR23B-deficient cells are NER proficient. In view of the
role of S. cerevisiae RAD23 in NER and the tight interaction of
mHR23B with XPC (26), we examined cellular survival of
wild-type, heterozygous, and homozygous mHR23B mutant
MEFs after exposure to increasing UV doses. Unexpectedly,
UV survival of mHR23B/ and mHR23B/ cells appeared
indistinguishable from that of the wild-type cells (Fig. 2A).
Moreover, mHR23B-deficient MEFs show normal DNA repair
synthesis (UDS [Fig. 2B]) and recovery of RNA synthesis after
UV exposure (Fig. 2C), indicating that neither GG-NER nor
TC-NER subpathways were affected. Also, in other respects
(e.g., morphology, growth rate, etc.), mHR23B-deficient MEFs
behaved normally. Assuming that a total mHR23 inactivation
would result in a DNA repair deficiency, as in S. cerevisiae (28,
48), these data suggest that mHR23A can fully substitute for
mHR23B, at least for its function in NER, not only in vitro but
also in vivo.
mHR23B deficiency causes impaired embryonic develop-
ment and intrauterine death. When (phenotypically normal)
heterozygous animals were crossed to produce mHR23B-defi-
cient mice, the targeted mHR23B allele was found to segregate
at a ratio far below that expected by Mendelian inheritance
(10-fold) (a total of 671 animals analyzed) (Table 1), sug-
gesting that a lack of mHR23B protein causes intrauterine
and/or perinatal death. Since mHR23B-deficient MEF lines
were obtained at an almost Mendelian ratio (data not shown),
lethal events must occur after day 13.5 of gestation (E13.5).
Analysis of a large series of embryos at different stages of
development revealed a near twofold reduction in the number
of viable mHR23B-deficient embryos between E13.5 and E15.5
(Table 1). Since at E18.5, 50% of the mHR23B-deficient em-
bryos were still alive (and the litters that were born contained
only 10% of the expected numbers of knockout animals), 80%
of the remaining embryos are assumed to have died immedi-
ately prior to, during, or shortly after birth, which is consistent
with the observed high number of dead newborn mHR23B/
mice.
mHR23B-deficient embryos (E13.5 to E19.5) showed clear
signs of growth retardation and were readily recognized by a
marked reduction in body size (Fig. 3). This is reflected by a
reduced body weight, which becomes more pronounced to-
wards term (data not shown). All mHR23B/ embryos alive at
stages E13.5 to E19.5 appeared pale, whereas major blood
FIG. 2. Repair characteristics of mHR23B-deficient MEFs. (A) UV survival curves of mHR23B/, mHR23B/, and mHR23B/ fibroblast
lines. Identical results were obtained with three other cell lines of mHR23B/ and mHR23B/ and with five other independent lines of
mHR23B/ MEFs (data not shown). XPC/ fibroblasts were included as a negative control. Cells were exposed to different doses of UV (254-nm
wavelength). After 4 or 5 days, the number of proliferating cells was estimated from the amount of radioactivity incorporated during a 3-h pulse
with [3H]thymidine. (B) Global genome repair (UDS) in mHR23B/, mHR23B/, and mHR23B/ fibroblast lines. Three other lines of
mHR23B/ and mHR23B/ and five independent lines of mHR23B/ were tested with consistent results (data not shown). XPA/ fibroblasts
were included as a negative control. Cells were irradiated with UV (16 J/m2) (254-nm wavelength) and labeled with [3H]thymidine. Incorporation
of radioactivity was measured by autoradiography and counting the grains (average of 50 nuclei per cell line) (the standard errors of the mean are
indicated by the error bars). (C) RNA synthesis recovery after UV exposure of mHR23B/, mHR23B/, and mHR23B/ fibroblast lines. Three
other lines of mHR23B/ and mHR23B/ and five other independent lines of mHR23B/ were assayed with similar outcome (data not shown).
CSB/ fibroblasts served as a negative control. At 16 h after exposure to different doses of UV (254-nm wavelength), the residual RNA synthesis
was measured by scintillation counting following a 1-h pulse-labeling with [3H]uridine. For each genotype, comparable results were obtained by
counting the grains after autoradiography (data not shown).
TABLE 1. Intrauterine and perinatal lethality of mHR23B/
mutants at different embryonic and fetal stages
Stage No. of micestudied








E13.5 70 17.5 14 1.3
E15.5 72 18.0 9 2.0
E18.5 162 40.5 19 2.1
Newborn 671 167.8 16 10.5
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vessels were not clearly visible (Fig. 3B and E). This suggests
that vascularization and/or blood supply was poor. In addi-
tion, large numbers of mHR23B/ embryos showed edema
(Fig. 3F). Also, embryos with interstitial bleeding through-
out the body were found (Fig. 3F). Moreover, in numerous
mHR23B/ embryos (E13.5 to E19.5), the eyelids were not
closed and the mouth was widely open, which is a characteristic
feature of maceration following embryonic death. Eyelid clo-
sure and fusion normally occur between E15.5 and E16.5 of
mouse embryonic development. A wide open mouth normally
indicates micrognathia or cleft lip resulting from retarded
growth of the mandible.
Preliminary histopathological examination of living mHR23B-
deficient E15.5 and E18.5 embryos revealed no obvious abnor-
mal architecture of vital organs and tissues, and the reduction
in organ weight appeared proportional to the reduction in total
body weight. However, in one mHR23B-deficient E18.5 em-
bryo, we observed an open secondary palate (cleft palate)
resulting from imperfect closure of the palatal shelves of the
maxilla (in normally developing embryos, this is completed at
E16; data not shown). Taken together, these data indicate that
the mHR23B protein is required for proper embryonic devel-
opment and that mHR23A cannot substitute or can substitute
only partly for this function.
Inactivation of mHR23B causes a placental defect. In line
with the pale appearance of a large number of mHR23B-
deficient embryos, the placentas of mHR23B/ mutants at
stage E18.5 (n  3) appeared pale and smaller compared to
mHR23B/ and mHR23B/ placentas. Histological exami-
nation revealed poor vascularization of mutant placentas, as
evident from the reduced number of fetal blood vessels in the
labyrinth (Fig. 4A and B). Transmission electron microscopy of
FIG. 3. Developmental impairment in mHR23B/ embryos at E15.5. mHR23B/ (A and D) and mHR23B/ (B, C, E, and F) embryos with
(A to C) and without (D to F) amniotic or chorionic plates and placentas. The embryo in panel A is identical to the embryo in panel D, and the
embryo in panel B is identical to that in panel E. mHR23B/ embryos display retarded growth and impaired vascularization (B and E),
intrauterine death (C), and internal bleeding (F).
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mHR23B/ placentas (n  3) revealed swollen trophoblas-
tic cells (Fig. 4C and D). In addition, altered morphology of
the vascular basement membrane of mHR23B/ placentas
was observed (Fig. 4D). The vascular basement membrane of
mHR23B/ placentas was darker and thicker than that of
wild-type placentas, which might affect the exchange of gases
and transport of nutrients and waste products.
mHR23B-deficient mice show retarded growth and facial dys-
morphology. Despite the pronounced impact of the mHR23B
deficiency on embryonic development, about one-tenth of the
expected number of homozygous mutant mice was found alive
in litters born from heterozygous breeding couples (Table 1).
Like mHR23B/ embryos, newborn homozygous mutant mice
showed a marked reduction in body size and are readily dis-
tinguishable from their heterozygous and wild-type littermates
(Fig. 5A). After the mice were weaned, we did not notice any
further weight loss of mHR23B/ animals. As evident from
body weight measurements, mHR23B/ mice display retard-
ed growth, particularly in the last days before weaning (day 21).
Up to 7 weeks after birth, the average body weight of homozy-
gous mutant males (n  4) and females (n  2) was still ap-
proximately 50% lower than that of wild-type (n  3) and
heterozygous (n  8) littermates (Fig. 5B). This situation re-
mained throughout life (body weight at 3 months shown in Fig.
5C). Vital organs were proportionally reduced in size (data not
shown). Adult mHR23B/ males and females (up to 1 year
and older) lacked fatty tissues, while excessive fat was observed
in the abdominal cavity of wild-type mice. However, histo-
pathological examination of the vital organs, sciatic nerve, and
skeletal muscle from adult mHR23B-deficient mice (n  4)
failed to reveal any obvious abnormality (data not shown).
All mHR23B-deficient mice and embryonic stages analyzed
from E16.5 on showed facial dysmorphology. The nose had a
blunted shape rather than the tapered appearance character-
istic for rodents due to hypoplasia of the maxilla and mandible
(Fig. 5D and E). In addition, more than one-third of the
mHR23B-deficient mice developed so-called elephant teeth
(overgrown teeth). The cause of death at 0.5 to 1 year of age
FIG. 4. Placental defect in mHR23B/ embryos at E18.5. Histological 1-m-thick sections (A and B) and transmission electron micrographs
(C and D) of mHR23B/ (A and C) and mHR23B/ (B and D) placentas. mHR23B/ placenta shows swollen trophoblastic cells (small black
arrows) and significantly reduced vascularization (blood vessels indicated by large black arrows and endothelial cells indicated by black arrow-
heads). Additionally, in contrast to normal placental labyrinth of the wild-type mouse placenta, the vascularization and vascular basement
membranes in the mutant placenta seem to be disturbed. Scale bars, 10 m.
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may be secondary to the poor overall condition of the mutant
mice. However, we did not observe cancer thus far.
mHR23B-deficient mice have ocular pathology. Some 7 to 10
days after birth, mHR23B-deficient mice started to develop eye
pathology, characterized by excessive eye fluid and swelling of
the eyelids. Animals refrained from opening their eyes widely.
Probably as a result of the continuously drenched eyes,
mHR23B-deficient mice showed excessive washing activities.
These features persisted into adulthood with frequent signs of
inflammation in eyelids (Fig. 5E) that could not be treated by
application of eye ointment (Terramycin containing oxytetra-
cycline-polymyxin). In addition, a large number of mHR23B-
deficient animals seemed to suffer from itching, as evident
from extensive scratching, which was not restricted to the head
region but also involved the ears and the neck line. Some
mHR23B-deficient mice had opaque eyes (data not shown).
FIG. 5. Growth retardation in mHR23B/ mice. (A) A 19-day-old wild-type male mouse (brown) and its smaller mHR23B/ (black)
littermate. (B) Growth curve of mHR23B mice. Data for mHR23B/ (n  3 [males]) (open diamonds), mHR23B/ (n  8 [5 males and 3
females]) (closed squares), and mHR23B/ (n  6 [4 males and 2 females]) (closed triangles) are shown. The average body weights (in grams)
were monitored for 5 weeks. (C) Average body weights (in grams) of 93-day-old mHR23B/ (n  8 [5 males and 3 females]) and mHR23B/
(n  6 [4 males and 2 females]) mice. Data are shown for males (black bars) and females (white bars). (D) Adult mHR23B/ mouse. (E) The
eyelids are inflamed in an adult mHR23B/ mouse and are surrounded by a large amount of tears or eye fluid. The head of a mHR23B/ mouse
appears irregularly shaped due to hypoplasia of the maxilla and mandible.
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Histological analysis of mHR23B-deficient mice (n 6) con-
firmed that the mice had conjunctivitis. In addition, in the
corners of the eyes of mHR23B-deficient mice, inflammation
cells containing polymorphic nuclei (neutrophils) were ob-
served possibly due to infections (data not shown). A clear
cause of the wet eyes was not detected. The tear-producing
glands showed no overt abnormalities. However, in one
mHR23B-deficient mouse, the number of conjunctival goblet
cells that produce the mucous layer of the tear film was deter-
mined (n  2) and found to be reduced. The drainage of the
tears was checked in one mHR23B-deficient animal and ap-
peared normal. Moreover, we failed to observe any abnormal-
ities in other parts of the eye, such as the retina (data not
shown).
To examine the possibility of any inflammatory disease, the
ratio of immunoglobulin A (IgA), IgG, and IgM and the white
blood cell counts of adult mHR23B-deficient mice (n 5) were
determined, but abnormalities were not found, indicating that
the immunological system is not compromised (data not shown).
Defective spermatogenesis in mHR23B/ male mice. At-
tempts to use mHR23B/ males in breeding protocols with
either mHR23B/ or wild-type female mice did not result in
pregnancies. Since mHR23B/ males show mating activity (as
evident from the presence of copulatory plugs in the female
mice), their inability to produce progeny appears not to be
related to either reduced body size (which may affect physical
sexual performance) or hormonal disturbances. Inspection of
the reproductive organs of adult mHR23B/ males (3.5 to 7
months of age; n  11) disclosed a disproportionate reduction
in the size of the testes (Fig. 6A). Whereas the weight of all
internal organs was proportional to the twofold reduction in
body weight, the weight of mHR23B/ testes was reduced by
about sevenfold. The weight of mHR23B/ epididymides and
seminal vesicles was reduced by about twofold (Fig. 6B).
Morphology of seminal vesicles of mHR23B-deficient males
(n  2) showed no abnormalities. However, histological exam-
ination of the testes of mHR23B-deficient males revealed sem-
iniferous tubules with a small diameter and relatively abundant
interstitial tissue in all animals analyzed (n 11) (Fig. 7). Most
striking is the total absence of spermatogenesis, which is in line
with the absence of sperm cells in the epididymis (Fig. 7B). In
the tubules, Sertoli cells appear to be the predominant cell type
(Fig. 7D and F). In the center of most tubules, we observed a
concentration of cells, which are typical of Sertoli cell clusters,
which represent Sertoli cells detached from the basal mem-
brane of the seminiferous tubule (Fig. 7D and F). Such clusters
were not observed in wild-type seminiferous tubules, contain-
ing all stages of spermatogenesis (Fig. 7C and E). Release of
Sertoli cells from the basal membrane and clustering in the
lumen has been observed in other male mouse sterility models,
particularly in the older animals (32).
The impairment of spermatogenesis in adult mHR23B-defi-
cient mice might reflect a primary defect, resulting in a block at
an early or later phase of spermatogenesis. To study this in
more detail, a histological analysis was performed on the testes
of 15-day-old mHR23B/ animals, when spermatogenesis is
normally initiated. Morphology of the testis of a mHR23B-
deficient mouse revealed no initiation of spermatogenesis com-
pared to normal initiation of spermatogenesis, with presence
of pachytene spermatocytes, in the testis of a wild-type mouse.
The majority of the tubules of the testis of a 15-day-old
mHR23B-deficient mouse showed a Sertoli-cell-only phenotype,
although a few tubules contained some spermatogonia (Fig. 7G
and H). Histological examination of an E15.5 mHR23B-defi-
cient male revealed normal urogenital morphology of Mülle-
rian duct regression and Wolffian duct development, indicating
testicular production of anti-Müllerian hormone (AMH) by
Sertoli cells and testosterone by the interstitial Leydig cells.
Although testicular histology of E15.5 mHR23B-deficient ani-
mals displayed normal Sertoli cells, the number of gonocytes
(originating from primordial germ cells) seemed to be reduced
compared to the testes of wild-type mice (Fig. 8).
mHR23B/ females exhibit reduced fertility. In contrast to
mHR23B homozygous mutant males, mHR23B/ females
(n  5) were fertile. However, compared to mHR23B/ or
mHR23B/ females, fertility of mHR23B-deficient females
(n 5) was clearly reduced. Copulatory plugs were found after
interbreeding with wild-type or mHR23B/ males, but litters
born from mHR23B-deficient females were consistently small-
er than normal (only one or two pups/litter). Histology of
mHR23B/ ovaries (n  3) showed a full spectrum of follic-
ular development including Graafian follicles and corpora
lutea, indicating normal endocrine regulation of ovarian func-
tion by follicle-stimulating hormone and luteinizing hormone
(data not shown).
Additional findings in mHR23B/ mice. A large proportion
of mHR23B-deficient mice frequently suffered from inflamed
or swollen anuses in parallel with ulcers, resulting from rectal
prolapse. Also, the mice had soft oily feces, which may point to
an intestinal malfunctioning. The skin of mHR23B-deficient
mice (n  16) appeared thinner than that of wild-type mice.
FIG. 6. The growth of the testes of mHR23B/ males is retarded.
(A) Macrograph of adult wild-type (left) and mHR23B/ (right) tes-
tes. Besides reduction in size, blood vessels are not clearly visible in
mHR23B/ testes. Scale bar, 5 mm. (B) Average weights of body and
sexual organs in wild-type and mHR23B/ male mice.
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FIG. 7. mHR23B/ males show impaired spermatogenesis and dysfunction of Sertoli cells. (A to F) Histological examination of 91-day-old
caput epididymis (A and B) and testis (C to F) from wild-type (A, C, and E) and mHR23B/ mice (B, D, and F). Epididymis of a wild-type mouse
(A) is filled with sperm cells, which are absent in the epididymal tubules of mHR23B/ mouse (B). Normal spermatogenesis led to spermatids
(small black arrow) and spermatozoa (black arrowhead) shown toward the lumen in wild-type mouse testis (C and E [panel E is a higher-mag-
nification view of the section shown in panel C]). In contrast, spermatogenesis is impaired in mHR23B/ testes (D and F [panel F is a higher-
magnification view of the section shown in panel D]). Seminiferous tubules of mHR23B/ testis show Sertoli cell nuclei at the normal position near the
basal membrane (black arrow) and Sertoli cell clusters (indicated by asterisks) in the lumen. (G and H) Histological sections of 15-day-old testis from
wild-type (G) and mHR23B/ (H) mice. Tubules of mHR23B/ testis show a Sertoli-cell-only phenotype, with predominant appearance of Sertoli cells
(black arrow points to Sertoli cell nucleus) compared to wild-type testis, with the presence of spermatocytes (small white arrow). Scale bars, 100 m.
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However, the skin of mHR23B-deficient mice (n  4) showed
no overt abnormalities compared with that of wild-type mice
(mHR23B/; n 2). In addition, the amount of subcutaneous
fat in mHR23B/ mice was comparable to that of wild-type
mice (data not shown). Finally, a few mHR23B-deficient mice
showed abnormal behavior, like jumping (n  3) and circling
or waltzing (n  1), although definite conclusions await anal-
ysis using several behavioral tests with a larger number of
animals.
DISCUSSION
mHR23 deficiency does not result in a NER defect. RAD23
mutants are unique among the S. cerevisiae NER mutants in
several respects. Despite an intermediate UV sensitivity, sug-
gesting partial NER impairment, deletion mutants of both S.
cerevisiae and Schizosaccharomyces pombe do not display, par-
adoxically, detectable global genome and transcription-cou-
pled repair, indicating that NER is completely disturbed (24,
46). Within the NER machinery, RAD23 is the only compo-
nent with multiple connections with the ubiquitin system. The
RAD23 protein has a ubiquitin-like N terminus that is essential
for its function in repair in vivo (48). The two ubiquitin-asso-
ciated domains within the protein are very strongly conserved,
which underlines their functional importance. The protein in-
teracts physically via its ubiquitin-like domain with compo-
nents of the 26S proteasome and inhibits multiubiquitination
in vitro (33, 35). In view of its strong interaction with RAD4, it
is likely that the main role of RAD23 in NER is mediated via
this repair component. Remarkably, S. cerevisiae RAD4 and
RAD23 appear to be involved in both NER subpathways,
whereas the mammalian counterpart of RAD4, XPC, is in-
volved only in GG-NER (28, 44). Of the two homologs of
RAD23 in mammals, hHR23B is the main partner of XPC
(26). The XPC-hHR23B heterodimer is identified as the first
initiator of damage recognition in global genome repair, and it
is also found to stimulate XPC in in vitro NER (38).
In this study, we have analyzed the function of mHR23B in
vivo by generating an mHR23B knockout mouse model. Sur-
prisingly, in contrast to S. cerevisiae, no apparent NER pheno-
type is detected in mHR23B-deficient cells, which are not UV
sensitive and show efficient global genome repair and tran-
scription-coupled repair (Fig. 2). These data demonstrate that
NER, and in particular the function of XPC, is not significantly
affected by the absence of mHR23B. Assuming that as in S.
cerevisiae, the mammalian RAD23 homologs are important for
NER, the most plausible interpretation for our findings is that
in the absence of mHR23B, the mHR23A protein can func-
tionally replace it, including the binding and stimulation of
XPC. This is consistent with the in vitro redundancy between
the human HR23 homologs in NER (39) and the recent iden-
tification of an XPC-hHR23A subcomplex in whole-cell ex-
tracts (1). These findings support an in vivo function of HR23A
in GG-NER. Thus, they argue against the model that the
HR23A protein specifically interacts with a hitherto unidenti-
fied second RAD4-like homolog in mammals specific for TC-
NER, so that both together would cover the function of the
single RAD4 and RAD23 genes in S. cerevisiae (14). However,
it remains puzzling why the HR23B protein is normally pre-
dominantly associated with XPC in living cells, whereas this
study suggests that HR23A appears to be equally able to per-
form this function in NER (37, 41). Therefore, the functional
distinction between HR23A and HR23B proteins is still unre-
solved.
Mice lacking mHR23B display a severe, unexpected pheno-
type. Whereas an apparent NER defect could not be detected,
mHR23B-deficient mice exhibit a severe phenotype, which is
quite different from the abnormalities observed in mouse mod-
els for other NER genes. A complete mHR23B deficiency
causes impaired embryonic development, poor vascularization,
growth retardation, male sterility, and facial dysmorphology
(Table 2). In contrast, inactivation of the mammalian XPC
gene, the other component of the XPC-mHR23B complex,
results in a GG-NER defect which is accompanied only by UV
sensitivity and UV-induced skin cancer predisposition (4, 34).
Even a total NER defect as demonstrated by XPA-deficient
FIG. 8. mHR23B/ embryos at E15.5 show impaired development of gonocytes. Histological analysis of the tubules of E15.5 testis from
wild-type (A) and mHR23B/ (B) mutants. Sertoli cell nuclei are indicated by black arrowheads. Compared to wild-type testis, tubules of
mHR23B/ testis show less gonocytes (black arrows). Scale bars, 10 m.
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mice allows apparently normal development and life span (11,
29).
Mutations in several NER factors can give rise to a spectrum
of additional features that at first glance seem not to be asso-
ciated with a NER defect. For example, patients with CS show
a combination of sun sensitivity, short stature, severe neuro-
logical abnormalities, and a characteristic bird-like facies, and
TTD patients also have ichthyosis and many symptoms of CS
(3, 7). These symptoms are explained by the fact that the cor-
responding proteins have additional functions outside the NER
context, particularly transcription. For instance, in the case of
the CSA and CSB mutants, sensitivity of the transcription pro-
cess to a wider range of lesions hampering transcription may
contribute to the severe developmental and neurological com-
plications and premature ageing of CS patients. Similarly, the
engagement of dual XPB and XPD helicases of TFIIH in both
NER and basal transcription initiation may give rise to the
typical TTD symptoms (8). However, the CS and TTD symp-
toms are quite distinct from the abnormalities exhibited by the
mHR23B mouse mutant. A condition with a superficial resem-
blance to the phenotype of mHR23B deficiency is cerebro-
oculo-facio-skeletal (COFS) syndrome which is considered
within the same differential diagnosis as CS (15). COFS is a
rare birth defect disorder with an autosomal recessive inheri-
tance characterized by progressive brain and eye defects lead-
ing to skeletal and craniofacial abnormalities, postnatal growth
deficiency, genital hypoplasia, and early death. It should be
kept in mind that such comparisons can be quite misleading,
and further research will be required to determine whether
mHR23B is implicated in some form of this disease or in other
human disorders. Our work demonstrates that mHR23B is
essential for normal development of the mouse and implies an
additional function besides its role in GG-NER, which is not
compensated or only partially compensated for by mHR23A.
mHR23B is essential for growth and development. The phe-
notypic abnormalities detected during the intrauterine devel-
opment of mHR23B-deficient mice included prenatal (or early
postnatal) death, disturbed growth, as well as abnormalities
involving improper differentiation of the vascular basement
membrane in the placental labyrinth and vascularization. The
placenta is essential for embryonic survival beyond E11.5, as it
forms vascular connections necessary for maternal-fetal ex-
change of gases, nutrients, and waste products (6). Thus, the
transport of nutrients to the embryo may be limited in the
damaged labyrinth region of homozygous mutant embryos.
This may explain a number of abnormal features, such as early
embryonic death, swollen trophoblast cells, small placenta, and
poor, delayed development resulting in smaller embryos. The
growth of mHR23B/ embryos that live beyond E11.5 ap-
pears to be retarded. We speculate that these embryos have a
placenta with sufficient function to allow survival to term but
not normal growth and development. This may also explain the
reduction in weight.
mHR23B deficiency is related to an ocular defect and facial
dysmorphology. Mice lacking mHR23B function exhibit wet
eyes and inflammation of the eyelids and conjunctiva. We
found no gross abnormalities in the tear-producing tissues, and
drainage of tears also appeared normal. However, the reduc-
tion of conjunctival goblet cells that was apparent in one of the
examined eyes may point to an involvement of vitamin A in this
phenotype. Vitamin A is necessary for proper differentiation
and maintenance of the mucosal epithelium. Lack of vitamin A
causes a depletion of goblet cells, which alters the composition
of the tear film and eventually can lead to xerosis and inflam-
mation of the eye (22). mHR23B-deficient mice may suffer
from vitamin A deficiency in conjunction with disturbed lipid
resorption. This would fit with other observations found for
mHR23B-deficient mice, such as reduced body weight, low
amount of body fat, and soft, oily feces (probably due to rectal
prolapse with an unknown cause).
mHR23B-deficient mice also display abnormalities of facial
and tooth development. It is possible that the biting or chewing
process is disturbed because of an imperfect positioning of the
dental elements in the maxilla and mandible. The facial ab-
normalities may be a direct result of subtle developmental
defects in the head region. However, reduced growth of the
palatal shelves is found in one mHR23B/ embryo. Since the
closure of the palate is of critical importance for proper food
intake and respiration, this could relate to the death of many
mHR23B-deficient animals around birth. Therefore, a more
systematic analysis of this feature to assess the biological sig-
nificance of this observation is warranted.
mHR23B is associated with male sterility. Disruption of
mHR23B causes defective spermatogenesis, resulting in the
absence of developing germ cells and a phenotype like that the
Sertoli cell-only syndrome. mHR23A and mHR23B are ex-
pressed in all mouse tissues and organs, but both genes show
enhanced mRNA levels in testis (42), suggesting that loss of
the encoded proteins may have specific gonadal consequences.
At E15.5, the tubules contain Sertoli cells with a normal his-
tological appearance. The fetal Sertoli cells have produced
AMH, as evidenced by Müllerian duct regression. However,
the number of gonocytes seemed somewhat reduced. At day 15
after birth, no initiation of spermatogenesis had taken place
and many Sertoli cells had become detached from the basal
membrane. The results indicate that failure of spermatogenesis
in mHR23B/ animals mainly occurs between E15.5 and day
15 after birth. The action of mHR23B may be involved in
development of a normal population of gonocytes, which is
capable to support initiation of spermatogenesis. In addition,
or alternatively, mHR23B may be required for the postnatal
initiation phase of spermatogenesis.
It is not clear why mHR23B/ females show decreased
TABLE 2. Summary of phenotypical analysis of mHR23B/ mice
Phenotypic trait No. of mice affected/no. of mice screened
Reduced body weight............................................................ 16/16
Eye pathology ........................................................................ 16/16
Fertility
Sterility in males ................................................................ 11/11
Reduced fertility in females ............................................. 5/5
Facial dysmorphology
Elephant teeth ...................................................................	6/16




Itching or washing .............................................................	3/16
Circling (waltzing) ............................................................. 1/16
Six toes on a foot............................................................... 1/16
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fertility, while ovarian histology is normal. The reduced fertility
of mHR23B/ females may result in part from the growth
retardation.
Other functional involvements of mHR23 proteins outside
NER may link to the ubiquitin proteolytic pathway. Interest-
ingly, the developmental abnormalities detected in mHR23B/
animals are absent in XPC and other NER-deficient mouse
mutants. This strongly suggests that mHR23B has a separate
important function, which may involve the ubiquitin/protea-
some pathway and which cannot be taken over by mHR23A. In
fact, studies in S. cerevisiae and mammals have shown that
RAD23 associates with the 26S proteasome and that hHR23
proteins play a role in cell cycle regulation (20, 23, 35). In
addition, the function of the two UBA domains in the RAD23
homologs is not known, though they are present in different
classes of enzymes involved in ubiquitin-dependent proteolysis
(21).
The ubiquitin system is essential in all cells and is involved in
modification of protein conformation and in degradation of
proteins. Numerous proteins are regulated through ubiquiti-
nation and therefore inhibition of the ubiquitin system fre-
quently results in a rapid dysregulation of multiple cellular
processes and subsequently in apoptosis. The effect of a partial
inhibition of ubiquitination is dependent upon the cell type:
although lethal to some cells, it is less critical to others. Knock-
out mouse models with a gametogenic failure suggest that the
ubiquitination machinery is important in gametogenesis (2,
13). During spermatogenesis, dramatic changes in protein
composition take place, which will require extensive use of the
ubiquitin/proteasome machinery. Different phases of mamma-
lian spermatogenesis probably require different specialized ac-
tivities of the ubiquitin system (2). Mouse models in which
genes encoding ubiquitination proteins are mutated result in
placental defect, embryonic lethality, abnormal facies, cleft
palate, and scratching behavior (18, 30, 31).
Taken together, our data suggest that the mammalian HR23
proteins have a broader function outside NER. To provide fur-
ther evidence, we are currently generating single knockout
HR23A mice and cells.
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